Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
bioCSL adds Immucor blood testing
The Immunohaematology division of bioCSL has added Immucor Corporation's global market-leading Capture technology platform and reagents to its prtfolio in Australia and New Zealand.
Approvals Action
Companies boost nicotine and haemophilia ranges
Baxter adds to haemophilia A portfolio while Medis Pharma registers six new brands of nicotine replacement therapy.
Pipeline Monitor
More indications for first-in-class cancer drug
BMS says it will file Opdivo for melanoma with the FDA adding the deadly skin cancer to a previous filing for NSCLC with more indications likely to come.
Open Forum
Digital - how to get it right
After years of working in pharma, Mark Razzell says the industry is yet to get digital right but believes there's hope for success through applying closed loop marketing principles to common research and promotional activities.
Working Life
Hiring hot spots for the coming year
More employers are planning to grow their headcount in pharma this financial year as increasing confidence translates into steady jobs growth, writes Karen Keast.